We used two different siRNA-TDP-43 oligos (i.e., a mix of siRNA-TDP-43 (B + C) oligos (see Materials and Methods)) (Figure 6), previously characterized for efficient TDP-43 knockdown in permissive cells for HIV-1 infection [12]. The gene discussed is TARDBP; the disease is HIV-1 infection.